Active ingredientAminolevulinic AcidCat. No. P-A126-001CAS 106-60-5Family · Pharmaceutical analytical standards
Aminolevulinic Acid
A natural amino acid, the first building block of the pathway leading to haem in blood and, in plants, to chlorophyll: in medicine it is used in photodynamic therapy and, in the United States since 2017, to make malignant gliomas visible during surgery. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The patient takes it by mouth before the operation: tumour cells turn it into protoporphyrin IX, which glows red to pink under violet-blue light of about 405 nm and guides the surgeon.
Go to the active ingredient →Active ingredientAminolevulinic AcidCat. No. P-A126-001CAS 106-60-5
Active ingredientAminolevulinic Acid HydrochlorideCat. No. P-A126-002CAS 5451-09-2
Pharmacopoeial impurityMethylaminolevulinate EP Impurity CCat. No. P-A126-003CAS 77479-01-7
Isotopically labelledMethylaminolevulinate EP Impurity B-d2 HydrochlorideCat. No. P-A126-004CAS 187237-35-0
Impurity5-Aminolevulinic Acid Impurity 1Cat. No. P-A126-005CAS 1688598-83-5
Impurity5-Aminolevulinic Acid Impurity 2Cat. No. P-A126-006No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
ImpurityMethylaminolevulinate impurity B CRSEDQM code Y0002278Family Aminolevulinic AcidImpurityMethylaminolevulinate impurity C CRSEDQM code Y0002279Family Aminolevulinic AcidNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.